Curious about Psilocybin? Prevalence and correlates of interest among adults with chronic pain.
Abstract
Chronic pain is a prevalent and disabling condition, making access to safe and effective pain treatments a public health priority. Early but encouraging results have emerged from research investigating the therapeutic potential of psilocybin for people living with chronic pain (PLCP). This growing line of work urges an understanding of PLCP’s receptivity to this treatment. <b>Aim</b>. The primary aim of this study was to evaluate the extent to which PLCP are interested in learning about psilocybin and factors that characterize interested individuals. The secondary aim was to compare these results to the prevalence and correlates of cannabis education interest. <b>Methods</b>. Individuals seeking care at an outpatient pain clinic in Western Canada (n = 949) completed a cross-sectional survey assessing current support needs, educational interests, physical and mental health, and demographics. <b>Results</b>. One-third (33.2%) indicated an interest in psilocybin education. Psilocybin interest was significantly related to depressive symptoms (r = 0.17), anxious symptoms (r = 0.10), lower financial wellbeing (r = -0.20), and younger age (r = -0.26). Nearly one-third (29.3%) of participants interested in learning about psilocybin were not interested in cannabis education. Compared to interest in cannabis education, interest in psilocybin education was more strongly correlated with depressive symptoms (z = 2.1, P = .033), lower financial wellbeing (z = -3.4, P < .001), and younger age (z = -6.7, P < .001). <b>Conclusion</b>. Results highlight a pressing need for evidence-based education for PLCP on psilocybin and a greater understanding of the informational needs of PLCP regarding this topic.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.